Press release

Atrys and the University of Barcelona present the 3rd edition of the UB Atrys Chair in Personalised Radiotherapy Awards

5 June 2024

  • Each year, this award honours the three best scientific articles published in internationally renowned journals in the field of radiation oncology.
  • The UB Atrys Chair was created with the firm intention of promoting progress in the field of precision radiation oncology in order to foster research excellence, specialised teaching and the dissemination of knowledge in this field

Atrys Health (ATRY), a global healthtech company that provides prevention, diagnosis and precision medical treatment services, pioneer in telemedicine and oncology treatment, and the University of Barcelona open the application process for participation in the 3rd edition of the Personalised Radiotherapy Research Awards, linked to the UB Atrys Chair created in 2021.

Each year, this award honours the three best scientific articles published in internationally renowned journals in the field of radiation oncology. The aim is to reward excellence and innovation in research, as well as to promote the dissemination of knowledge in this crucial area for the advancement of cancer treatment.

The total amount earmarked for these prizes is 9,000 euros divided into a first prize of 5,000 euros, a second prize of 3,000 euros and a third prize of 1,000 euros.

All applications received will be reviewed by the evaluation committee of the awards, formed by members of the Chair’s management, the presidency of the Spanish Society of Radiation Oncology (SEOR) and the management of the Institute for Research in Radiation Oncology (IRAD). The selected proposal will be notified to the rector, who will issue the resolution to award the prizes, which will be presented at the symposium ‘Towards a more inclusive, interactive and intelligent horizon’ that will take place during the XXII National Congress of the SEOR to be held in Oviedo on 25-27 September 2024.

The UB Atrys Chair was created with the firm purpose of promoting progress in the field of precision radiation oncology, focusing on three main lines of action: promoting research excellence, specialised teaching and the dissemination of knowledge in the field of radiation oncology. The aim is to achieve greater personalisation of radiotherapy treatments, optimising their efficacy and minimising side effects; to carry out predictive diagnoses prior to treatment in order to select the most appropriate treatment for each case; and to understand how radiotherapy can stimulate the immune response against cancer and develop new therapeutic strategies based on immunotherapy.

Interested researchers will find all the information about the awards and will be able to register via this link until 23:00h on 28 June 2024.